Figure 4
From: The contribution of peroxynitrite generation in HIV replication in human primary macrophages
MnTBAP inhibits MDA in HIV-infected macrophages in a dose dependent fashion. MDA increased within HIV-1-infected macrophages. Treatment with MnTBAP (0,24–30 μM) antagonized MDA overproduction dose-dependently while AZT (0.05 μM) was not able to inhibit macrophages HIV-related MDA formation. †P < 0.001 when compared to control; * P < 0.05 and ** P < 0.001 when compared to HIV-infected cells.